% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • donzoab donzoab Aug 10, 2006 4:11 PM Flag

    Cephelon's adhd drug sparlon REJECTED

    by fda. not approvable. Shires drugs king of the hill again. So much for all the hype on this drug.
    Should help shpgy move into the 50's and above.
    Extends the time table to sell drugs on the market w/o competition as they improve their pipeline and move other trials to Phase 3 and beyond.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • i found this on some pharma chat board. it's pretty funny to see the reps go at it.

      mcneil reps will be gone when concerta goes generic

      lilly reps don't count because doctors know strattera sucks

      novartis reps sell an 8 hour product that's peaked at a market share of 5%

      UCB reps, i've never even seen one

      Shire Reps- Two adhd products on the market and Four in the pipeline